CHU Estaing - Service Thérapie Cellulaire et Hématologie Clinique

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 1 / Phase 2	2026-02-11		NCT07018752

Clinical trials